|
Re: A Leading Indicator Of Success: Failure And Risk In Biotechnology
|
1
|
Mannkind
|
Jul 08, 2013 11:37PM
|
|
Re: A Leading Indicator Of Success: Failure And Risk In Biotechnology
|
1
|
Mannkind
|
Jul 08, 2013 11:25PM
|
|
Jefferies conference transcript
|
1
|
Mannkind
|
Jul 08, 2013 11:17PM
|
|
A Leading Indicator Of Success: Failure And Risk In Biotechnology
|
1
|
Mannkind
|
Jul 08, 2013 04:44PM
|
|
Re: Inhaled Insulin: Biotech Triumph or Future Flop?
|
1
|
Mannkind
|
Jul 08, 2013 12:54PM
|
|
Re: Insider Trading Alert - Chesapeake Energy And 3 Others Traded By Insiders
|
|
Mannkind
|
Jul 05, 2013 04:15PM
|
|
Insider Trading Alert - Chesapeake Energy And 3 Others Traded By Insiders
|
1
|
Mannkind
|
Jul 05, 2013 11:51AM
|
|
Re: MannKind Corporation to Present at 8th Annual JMP Securities Healthcare Conferen
|
|
Mannkind
|
Jul 04, 2013 10:59AM
|
|
MannKind Corporation to Present at 8th Annual JMP Securities Healthcare Conferen
|
1
|
Mannkind
|
Jul 03, 2013 05:27PM
|
|
Re: Hypoglycemia on the Rise
|
6
|
Mannkind
|
Jul 03, 2013 03:01PM
|
|
Zack's
|
|
Mannkind
|
Jul 03, 2013 11:52AM
|
|
Trade Flow Report for MannKind (MNKD) [07/02/2013]
|
4
|
Mannkind
|
Jul 02, 2013 10:29PM
|
|
Re: Form 4
|
|
Mannkind
|
Jul 02, 2013 10:19PM
|
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 02, 2013 10:11AM
|
|
Re: MannKind announces $160M debt financing
|
1
|
Mannkind
|
Jul 01, 2013 12:51PM
|
|
Starting Insulin for Type 2 Diabetes: When, Why,
|
1
|
Mannkind
|
Jun 30, 2013 12:30PM
|
|
Who Really, Really Wants Some More Pfizer Stock?
|
1
|
Mannkind
|
Jun 29, 2013 06:44PM
|
|
Re: Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
1
|
Mannkind
|
Jun 28, 2013 10:20AM
|
|
Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
|
Mannkind
|
Jun 28, 2013 09:03AM
|
|
Re: New SA Article
|
1
|
Mannkind
|
Jun 27, 2013 06:57PM
|
